<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062136</url>
  </required_header>
  <id_info>
    <org_study_id>VinmecISC1915</org_study_id>
    <nct_id>NCT04062136</nct_id>
  </id_info>
  <brief_title>Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia</brief_title>
  <official_title>Outcomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vinmec Research Institute of Stem Cell and Gene Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vinmec Research Institute of Stem Cell and Gene Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells
      transplantation in patients with bronchopulmonary dysplasia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord
      mesenchymal stem cells in 10 patients with bronchopulmonary dysplasia at Vinmec International
      Hospital, Hanoi, Vietnam
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse events and serious adverse events</measure>
    <time_frame>during 9 months post treatment</time_frame>
    <description>Incidence of the adverse events or serious adverse events after transplantation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The proportion of patients win from oxygen</measure>
    <time_frame>during 9 months post treatment</time_frame>
    <description>To identify the proportion of patient with Bronchopulmonary Dysplasia win from oxygen after stem cell transplantation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The lung fibrosis</measure>
    <time_frame>at 6 months post treatment</time_frame>
    <description>Changes of the lung fibrosis on chest CT at 6 months compared with baseline</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>Stem cell transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 million umbilical Cord Mesenchymal Stem Cells per body kg will transplant via the intravenous at baseline, and the second transplantation will be performed 1 week after the first transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>stem cell transplantation</intervention_name>
    <description>Transplantation of umbilical cord mesenchymal stem cells</description>
    <arm_group_label>Stem cell transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is diagnosis Bronchopulmonary Dysplasia (premature and depends on oxygen
             until 28 days old

          -  Gender: either sex

          -  Year old &lt; 6 months

          -  Weight â‰¥ 2 kg

          -  Agree to participate in the study.

        Exclusion Criteria:

          -  Severe congenital malformation.

          -  Other severe conditions (active pulmonary bleeding, evidence of active infections).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Liem T Nguyen, MD., PhD</last_name>
    <phone>(+844)39743556</phone>
    <phone_ext>1420</phone_ext>
    <email>v.liemnt@vinmec.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thai H Trieu Thi, MD</last_name>
    <phone>(+8424) 3974 3556</phone>
    <email>v.thaitth@vinmec.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vinmec Research Institute of Stem Cell and Gene Technology</name>
      <address>
        <city>Hanoi</city>
        <zip>100000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liem T Nguyen, MD., PhD</last_name>
      <phone>(+844)39743556</phone>
      <phone_ext>1420</phone_ext>
      <email>v.liemnt@vinmec.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vinmec Research Institute of Stem Cell and Gene Technology</name>
      <address>
        <city>Hanoi</city>
        <zip>100000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nguyen Thanh Liem, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <results_reference>
    <citation>Ahn SY, Chang YS, Kim SY, Sung DK, Kim ES, Rime SY, Yu WJ, Choi SJ, Oh WI, Park WS. Long-term (postnatal day 70) outcome and safety of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury. Yonsei Med J. 2013 Mar 1;54(2):416-24. doi: 10.3349/ymj.2013.54.2.416.</citation>
    <PMID>23364976</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, Park WS. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014 May;164(5):966-972.e6. doi: 10.1016/j.jpeds.2013.12.011. Epub 2014 Feb 6.</citation>
    <PMID>24508444</PMID>
  </results_reference>
  <results_reference>
    <citation>Liem NT, Anh TL, Thai TTH, Anh BV. Bone Marrow Mononuclear Cells Transplantation in Treatment of Established Bronchopulmonary Dysplasia: A Case Report. Am J Case Rep. 2017 Oct 12;18:1090-1094.</citation>
    <PMID>29021519</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchopulmonary dysplasia</keyword>
  <keyword>umbilical cord mesenchymal stem cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

